GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

GRAIL (Nasdaq: GRAL) will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2, 2025 at 3:00 p.m. ET.

Rhea-AI Summary

GRAIL (Nasdaq: GRAL) will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2, 2025 at 3:00 p.m. ET.

Company management's presentation will be available via live webcast and replay at investors.grail.com. The webcast will be archived and available for at least 30 days after the event.

Argus Nov 19 session

+7.99% close to close Open Argus

Details

News Market Reaction – GRAL

On Nov 19, the first trading day after this news, GRAL closed 7.99% above the previous close.

Data tracked by StockTitan Argus for the Nov 19 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2 at 3:00 p.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-piper-sandler-37th-annual-healthcare-conference-302618810.html

SOURCE GRAIL, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will GRAIL (GRAL) present at the Piper Sandler 37th Annual Healthcare Conference?

GRAIL will present on Tuesday, Dec. 2, 2025 at 3:00 p.m. ET.

How can investors watch the GRAIL (GRAL) presentation on Dec. 2, 2025?

Investors can watch the live webcast or replay at investors.grail.com.

Will the GRAIL (GRAL) webcast be available after the Piper Sandler conference?

Yes, the webcast will be archived and available for replay for at least 30 days after the event.

What topics will GRAIL (GRAL) management cover at the Piper Sandler conference?

The announcement states management will present company developments and outlook; no specific topics were detailed.

Is registration required to view GRAIL (GRAL) webcast on investors.grail.com?

The announcement directs viewers to investors.grail.com for live and replay webcasts; it does not specify registration requirements.